Would a Varian Acquisition by GE Help GE in Its Long-Term Goals?
Varian shares were up as much as 10% on Thursday after a report that GE might be acquiring the medical devices and equipment company.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 191
Why Rigel Pharma Is Falling
Rigel Pharmaceuticals shares slid on Thursday after the company announced results from its late-stage clinical trial.
How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs
Americans generally would like to spend less money on health care. One way that this can be and will be accomplished is through the continued use and expanded use of generic drugs.
Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains
These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.
iRhythm Technologies Announces IPO Pricing
iRhthym Technologies has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Puma Biotech Gears Up for Secondary Offering
Puma Biotechnology, Inc. (NYSE: PBYI) recently filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. No pricing details were announced, except that the offering would be valued up to $150…
Nektar Slides on Secondary Offering Pricing
Nektar Therapeutics plans to price 13 million shares at $13.50 for a secondary offering valued up to almost $202 million.
Is Settling With an Activist Investor Supposed to Be Bad for Shareholders?
Depomed has settled with Starboard Value in a move that will bring this activist investor fight to a close. At least for now.
Johnson & Johnson Remains Flat Despite Earnings Beat
Johnson & Johnson released a better-than-expected third-quarter report before the markets opened on Tuesday.
Jefferies Biotech and Health Care Momentum Stocks to Buy With Big Upside Potential
A new research report from Jefferies notes that when price momentum has been as bad as it has been recently, it tends to rebound in a big way.
UnitedHealth Raises EPS Forecast as Profits Post Double-Digit Increase
UnitedHealth Group reported better-than-expected third-quarter 2016 results before markets opened Tuesday morning.
ContraVir Continues to Win on More Positive HBV Updates
ContraVir Pharmaceuticals watched its shares make a handy gain in Monday’s session after the company announced a positive development in its mid-stage hepatitis B trial.
What to Look for in Johnson & Johnson Earnings
Johnson & Johnson is expected to release its most recent earnings report before the markets open on Tuesday.
Will PTC’s FDA Denial Interrupt Its Growth Plans?
PTC Therapeutics shares took a dive early on Monday after the company announced a key FDA decision that wasn’t good.
How ContraVir Pharma Won Big on Its HBV Interim Results
ContraVir Pharmaceuticals Inc. (NASDAQ: CTRV) is watching its shares climb on Thursday after the company reported positive interim data from its ongoing Hepatitis B (HBV) mid-stage trial. Specifically, the company announced data for CMX157,…